Novel genomic imbalances in b-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics

American Journal of Pathology

Volumn 158, Issue 5, 2001, Pages 1843-1850

  Hernández, Jesús María ^a,d   García, Juan Luis ^a   Gutiérrez, Norma Carmen ^a   Mollejo, Manuela ^b   Martínez Climent, José Angel ^c   Flores, Teresa ^a   González, María Belén ^a   Piris, Miguel Angel ^b   San Miguel, Jesús F ^a  

^a Centro de Investigacion del Cancer   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER SURVIVAL; CHROMOSOME 12Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 20Q; CHROMOSOME 3Q; CHROMOSOME 4Q; CHROMOSOME 5P; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME 9Q; CHROMOSOME DUPLICATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CORRELATION FUNCTION; CYTOGENETICS; FEMALE; HUMAN; HUMAN TISSUE; MALE; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; SPLEEN CANCER;

EID: 0035022371     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64140-5     Document Type: Article

References (53)

1. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November, 1997
2. Splenic marginal zone lymphoma: A distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases
3. Bcl 10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types
4. The apoptosis inhibitor gene APl2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas
5. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features
6. Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma
7. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue
8. Trisomy 3 in marginal zone B-cell lymphoma: A study based on cytogenetic analysis and fluorescence in situ hybridization
9. Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas
10. Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria
11. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma
12. Molecular delineation of the commonly deleted segment in mature B-cell lymphoid neoplasias with deletion of 7q
13. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
14. Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses
15. DNA copy number changes in diffuse large B-cell lymphoma - Comparative genomic hybridization study
16. High-level DNA amplifications are common genetic aberrations in B-cell neoplasms
17. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization
18. Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract
19. The histopathology of splenic lymphoma with villous lymphocytes
20. Molecular analysis of chromosome aberrations. In situ hybridization
21. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype/genotype correlation
22. Frequent loss of the 11q14-24 region in chronic lymphocytic leukemia: A study by comparative genomic hybridization
23. Consistent copy number gain in chromosome 12 in primary diffuse large cell lymphomas of the stomach
24. Structural abnormalities of chromosome 7q in chronic lymphoproliferative disorders
25. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations
26. Phi-positive and Phi-negative abnormal cell lines in a child with lymphoblastic lymphoma
27. A new chromosomal anomaly associated with mature B-cell chronic lymphoproliferative disorders: Del(7)(q32)
28. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma
29. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants
30. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene
31. Trisomy 5 and t(5;14)(q11;q32) as the sole abnormalities in two different clones from a centroblastic non-Hodgkin's lymphoma
32. Abnormal cell cycle regulation in malignancy
33. Characterization of a hairy cell leukemia-associated 5q 13.3 inversion breakpoint
34. Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions
35. Chromosomal translocations and gene rearrangements in non-Hodgkin lymphomas
36. Cytogenetic evolution patterns in non-Hodgkin's lymphoma
37. Chromosomal and gene amplifications in diffuse large B-cell lymphoma
38. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization
39. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors
40. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization
41. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization
42. Genetic analysis of benign, low-grade, and high-grade ovarian tumors
43. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization
44. The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q 13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines
45. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines
46. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
47. Differential regulation of mRNAs encoding three protein-tyrosine phosphatases by insulin and activation of protein kinase C
48. Myb12 (Bmyb) maps to mouse chromosome 2 and human chromosome 20q 13.1
49. Gene amplification in non-Hodgkin's lymphoma
50. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets to early amplicons